Scott Stricklin
Story Poster
55:45
Lunch with Liucci: Billy Liucci joins TexAgs Live (Monday, November 11)
10 days ago by Billy Liucci
TexAgs co-owner and executive editor Billy Liucci joined TexAgs Live on Monday morning as No. 15 Texas A&M prepares for New Mexico State following its second open date. Liucci discusses the Aggies' remaining slate and what's happening around the SEC.
Story Poster
19:46
SEC Mike shares his key storylines as A&M rolls into Gainesville
2 mo ago by Billy Liucci
Mike Elko's first-year Aggies will travel to "The Swamp" to open their SEC slate. Michael Bratton, aka "SEC Mike," joined Friday's edition of TexAgs Live to discuss the biggest storylines surrounding the clash, including questions at starting quarterback for both squads.
Story Poster
50:12
Ask Liucci: Super Bowl takeaways, Aggie football's offseason & more
9 mo ago by Billy Liucci
Back from Las Vegas where he did NOT attend a classic Super Bowl, TexAgs' co-owner and executive editor Billy Liucci sat down to tackle another round of subscriber questions. In this edition of Ask Liucci, "The Source" touched on Texas A&M football, Aggie baseball & more.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
35:44
Lunch with Liucci: Billy Liucci joins TexAgs Radio (Friday, January 19)
10 mo ago by Billy Liucci
TexAgs co-owner and executive editor Billy Liucci joined TexAgs Radio on Friday morning to discuss the state of Texas A&M's search for a new athletic director. "The source" also shared what he hopes happens in the divisional round of the NFL playoffs and much more.
Story Poster
23:03
Series Preview: Texas A&M vs. Georgia
3 yr ago by David Sandhop
Olsen Field at Blue Bell Park hosts its first Southeastern Conference series of the season as Texas A&M welcomes Georgia to Aggieland for a three-game set this weekend. David Sandhop shares what to expect from the Aggies and Bulldogs.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.